More News

18 Jul 2019 Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
18 Jul 2019 Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
17 Jul 2019 PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
17 Jul 2019 Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
17 Jul 2019 Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery
16 Jul 2019 Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
16 Jul 2019 Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
16 Jul 2019 Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech
16 Jul 2019 Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California
15 Jul 2019 AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
15 Jul 2019 Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
15 Jul 2019 Recordati to acquire worldwide rights to Signifor® and Osilodrostat (LCI699)
15 Jul 2019 Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
12 Jul 2019 Genmab and BliNK Biomedical Enter into Commercial License Agreement
11 Jul 2019 Report Package: Bispecific Antibodies
11 Jul 2019 vasopharm Closes € 9.5 million Financing Round
10 Jul 2019 AiCuris and Lysando join forces in the fight against antimicrobial resistance
10 Jul 2019 Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
09 Jul 2019 Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
09 Jul 2019 Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
09 Jul 2019 Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
09 Jul 2019 IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
09 Jul 2019 ADC Therapeutics Announces Final Close of Series E Financing Expansion
09 Jul 2019 BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
09 Jul 2019 MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up